acetazolamide has been researched along with Ischemic Attack, Transient in 51 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Blood flow velocity (BFV) in the middle cerebral artery at rest and cerebrovascular reserve capacity (CVRC) (percent rise in BFV after acetazolamide stimulation) measured by means of transcranial Doppler sonography were studied many years after aneurysmal subarachnoid hemorrhage in patients with proven cerebral vasospasm (mean BFV > 160 cm/s)." | 7.69 | Cerebrovascular reserve capacity many years after vasospasm due to aneurysmal subarachnoid hemorrhage. A transcranial Doppler study with acetazolamide test. ( Ficzere, A; Novak, L; Rozsa, L; Sheth, RN; Szabo, S, 1997) |
| "Prediction of cerebral infarction due to vasospasm (VS) following aneurysmal subarachnoid haemorrhage (SAH) was investigated using acetazolamide-activated (A-A) N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) single photon emission computed tomography (SPECT) in 79 SAH patients." | 7.68 | Prediction of cerebral infarction due to vasospasm following aneurysmal subarachnoid haemorrhage using acetazolamide-activated 123I-IMP SPECT. ( Funakoshi, T; Kimura, T; Shinoda, J, 1993) |
| " antiplatelet therapy), indicating a repeat TIA or ischemic stroke attack was noted during maximal medical therapy; having poor cerebral perfusion on CT imaging; and having regional cerebrovascular reactivity (rCVR) of <20% when acetazolamide challenge was undergone." | 3.78 | Extracranial-intracranial (EC-IC) bypass of symptomatic middle cerebral artery (MCA) total occlusion for haemodynamic impairment patients. ( Chang, JH; Chen, CC; Cheng, YW; Cho, DY; Chou, CW; Lin, SZ, 2012) |
| "Blood flow velocity (BFV) in the middle cerebral artery at rest and cerebrovascular reserve capacity (CVRC) (percent rise in BFV after acetazolamide stimulation) measured by means of transcranial Doppler sonography were studied many years after aneurysmal subarachnoid hemorrhage in patients with proven cerebral vasospasm (mean BFV > 160 cm/s)." | 3.69 | Cerebrovascular reserve capacity many years after vasospasm due to aneurysmal subarachnoid hemorrhage. A transcranial Doppler study with acetazolamide test. ( Ficzere, A; Novak, L; Rozsa, L; Sheth, RN; Szabo, S, 1997) |
| "Prediction of cerebral infarction due to vasospasm (VS) following aneurysmal subarachnoid haemorrhage (SAH) was investigated using acetazolamide-activated (A-A) N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) single photon emission computed tomography (SPECT) in 79 SAH patients." | 3.68 | Prediction of cerebral infarction due to vasospasm following aneurysmal subarachnoid haemorrhage using acetazolamide-activated 123I-IMP SPECT. ( Funakoshi, T; Kimura, T; Shinoda, J, 1993) |
| "Transient ischemic attacks and cerebral infarction were the common symptoms in these patients." | 2.47 | Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment. ( Murakami, H; Nakagawa, T; Ohba, S, 2011) |
| "The patient who suffered the recurrence presented an exhausted CRC and the collateral circulation was less favourable in the symptomatic hemisphere." | 1.40 | [Bilateral carotid artery occlusion: prognosis and neurosonological features]. ( Díaz-Otero, F; Fernández-Bullido, Y; García-Pastor, A; Gil-Núñez, A; Pérez-Sánchez, JR; Rodríguez-Cruz, PM; Sobrino-García, P; Vázquez-Alén, P; Vicente-Peracho, G; Villanueva-Osorio, JA, 2014) |
| "Young patients with moyamoya disease frequently exhibit extensive cerebral infarction at the time of initial presentation, and even in the early postoperative period." | 1.36 | Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. ( Fujimura, M; Hayashi, T; Shirane, R; Tominaga, T, 2010) |
| "Nine patients symptomatic with transient ischemic attacks and strokes, and with occlusive vascular disease were studied." | 1.33 | Differentiating hemodynamic compromise by the OEF response to acetazolamide in occlusive vascular disease. ( Chang, Y; Gebel, J; Hammer, MD; Jovin, T; Kuwabara, H; Nemoto, EM; Pindzola, R; Sashin, D; Wechsler, L; Yonas, H, 2005) |
| "Limb shaking in Moyamoya disease may result from a transient hypoperfusion of the contralateral frontoparietal cortex rather than basal ganglia." | 1.32 | Hyperventilation-induced limb shaking TIA in Moyamoya disease. ( Chung, CS; Han, DH; Kim, HY; Lee, J; Lee, KH, 2003) |
| "An angiogram showed the focal stenosis of the anterior cerebral artery." | 1.32 | Hemodynamic changes in limb shaking TIA associated with anterior cerebral artery stenosis. ( Han, SW; Heo, JH; Kim, JK; Kim, SH; Park, CH; Yun, MJ, 2004) |
| "Acetazolamide challenge was not performed." | 1.29 | Persisting perfusion defect in transient ischemic attacks: a new clinically useful subgroup? ( De Coster, P; Jamart, J; Laloux, P; Laterre, C; Meurisse, H, 1996) |
| "Clinical manifestations included rare transient ischemic attacks (in one of 15 patients), intermittent basilar symptoms (in 15 of 15 patients), and a subacute vertebrobasilar "threatening" syndrome." | 1.28 | Nuclear hemodynamic vertebrobasilar insufficiency. A new approach with the xenon Xe 133 method. ( Nighoghossian, N; Philippon, B; Trouillas, P, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (23.53) | 18.7374 |
| 1990's | 25 (49.02) | 18.2507 |
| 2000's | 9 (17.65) | 29.6817 |
| 2010's | 4 (7.84) | 24.3611 |
| 2020's | 1 (1.96) | 2.80 |
| Authors | Studies |
|---|---|
| Deckers, PT | 1 |
| van Hoek, W | 1 |
| Kronenburg, A | 1 |
| Yaqub, M | 1 |
| Siero, JCW | 1 |
| Bhogal, AA | 1 |
| van Berckel, BNM | 1 |
| van der Zwan, A | 1 |
| Braun, KPJ | 1 |
| Pérez-Sánchez, JR | 1 |
| García-Pastor, A | 1 |
| Díaz-Otero, F | 1 |
| Sobrino-García, P | 1 |
| Rodríguez-Cruz, PM | 1 |
| Vicente-Peracho, G | 1 |
| Vázquez-Alén, P | 1 |
| Fernández-Bullido, Y | 1 |
| Villanueva-Osorio, JA | 1 |
| Gil-Núñez, A | 1 |
| Hayashi, T | 1 |
| Shirane, R | 1 |
| Fujimura, M | 1 |
| Tominaga, T | 1 |
| Ohba, S | 1 |
| Nakagawa, T | 1 |
| Murakami, H | 1 |
| Chou, CW | 1 |
| Chang, JH | 1 |
| Lin, SZ | 1 |
| Cho, DY | 1 |
| Cheng, YW | 1 |
| Chen, CC | 1 |
| Kim, HY | 1 |
| Chung, CS | 1 |
| Lee, J | 1 |
| Han, DH | 1 |
| Lee, KH | 1 |
| Okudaira, Y | 1 |
| Nakanishi, H | 1 |
| Arai, H | 1 |
| Sato, K | 1 |
| FAZEKAS, JF | 2 |
| ALMAN, RW | 2 |
| TICKTIN, HE | 1 |
| EHRMANTRAUT, WR | 1 |
| SAVARESE, CJ | 1 |
| Belardi, P | 1 |
| Lucertini, G | 1 |
| Han, SW | 1 |
| Kim, SH | 1 |
| Kim, JK | 1 |
| Park, CH | 1 |
| Yun, MJ | 1 |
| Heo, JH | 1 |
| Hammersen, F | 1 |
| Lübcke, N | 1 |
| Lüders, S | 1 |
| Diener, HC | 1 |
| Schrader, J | 1 |
| Nemoto, EM | 1 |
| Yonas, H | 2 |
| Kuwabara, H | 1 |
| Pindzola, R | 1 |
| Sashin, D | 1 |
| Chang, Y | 1 |
| Jovin, T | 1 |
| Gebel, J | 1 |
| Hammer, MD | 1 |
| Wechsler, L | 1 |
| McDowell, HA | 1 |
| Clark, LC | 1 |
| Galbraith, JG | 1 |
| Asenbaum, S | 1 |
| Reinprecht, A | 1 |
| Brücke, T | 1 |
| Wenger, S | 1 |
| Podreka, I | 1 |
| Deecke, L | 1 |
| Nariai, T | 3 |
| Suzuki, R | 3 |
| Hirakawa, K | 3 |
| Maehara, T | 1 |
| Ishii, K | 2 |
| Senda, M | 2 |
| Smith, HA | 1 |
| Thompson-Dobkin, J | 1 |
| Flint, E | 1 |
| Matsushima, Y | 2 |
| Ichimura, K | 1 |
| Kimura, T | 1 |
| Shinoda, J | 1 |
| Funakoshi, T | 1 |
| Tran Dinh, YR | 1 |
| Lot, G | 2 |
| Benrabah, R | 1 |
| Baroudy, O | 1 |
| Cophignon, J | 1 |
| Seylaz, J | 1 |
| Laloux, P | 1 |
| Jamart, J | 1 |
| Meurisse, H | 1 |
| De Coster, P | 1 |
| Laterre, C | 1 |
| Levine, RL | 2 |
| Turski, PA | 2 |
| Turnipseed, WD | 2 |
| Grist, T | 1 |
| Yoshida, K | 1 |
| Nakamura, S | 1 |
| Watanabe, H | 2 |
| Kinoshita, K | 1 |
| Vorstrup, S | 3 |
| Haase, J | 1 |
| Waldemar, G | 1 |
| Andersen, A | 1 |
| Schmidt, J | 1 |
| Paulson, OB | 1 |
| Stoll, M | 1 |
| Hamann, GF | 1 |
| Jost, V | 1 |
| Bompotti, UA | 1 |
| Fitridge, R | 1 |
| Schimrigk, K | 1 |
| Gückel, FJ | 1 |
| Brix, G | 1 |
| Schmiedek, P | 1 |
| Piepgras, Z | 1 |
| Becker, G | 1 |
| Köpke, J | 1 |
| Gross, H | 1 |
| Georgi, M | 1 |
| Ohta, S | 1 |
| Oka, Y | 1 |
| Kumon, Y | 1 |
| Sakaki, S | 1 |
| Sugawara, Y | 1 |
| Tanada, S | 1 |
| Iwama, T | 1 |
| Hashimoto, N | 1 |
| Takagi, Y | 1 |
| Tsukahara, T | 1 |
| Hayashida, K | 1 |
| Isaka, Y | 2 |
| Nagano, K | 1 |
| Narita, M | 1 |
| Ashida, K | 2 |
| Imaizumi, M | 2 |
| Dulli, DA | 1 |
| Grist, TM | 1 |
| Szabo, S | 1 |
| Sheth, RN | 1 |
| Novak, L | 1 |
| Rozsa, L | 1 |
| Ficzere, A | 1 |
| Oishi, M | 1 |
| Mochizuki, Y | 1 |
| Shikata, E | 1 |
| Mizutani, T | 1 |
| Martí-Fàbregas, JA | 1 |
| Catafau, AM | 1 |
| Marí, C | 1 |
| Mendoza, G | 1 |
| Sanahuja, J | 1 |
| Lleó, A | 1 |
| Martí-Vilalta, JL | 1 |
| Sterzer, P | 1 |
| Meintzschel, F | 1 |
| Rösler, A | 1 |
| Lanfermann, H | 1 |
| Steinmetz, H | 1 |
| Sitzer, M | 1 |
| George, B | 1 |
| Mourier, KL | 1 |
| Iiji, O | 1 |
| Cikrit, DF | 2 |
| Burt, RW | 2 |
| Dalsing, MC | 1 |
| Lalka, SG | 1 |
| Sawchuk, AP | 1 |
| Waymire, B | 1 |
| Witt, RM | 2 |
| Reddy, RV | 1 |
| Trouillas, P | 1 |
| Nighoghossian, N | 1 |
| Philippon, B | 1 |
| Dingler, WH | 1 |
| Deininger, HK | 1 |
| Russell, D | 1 |
| Dybevold, S | 1 |
| Kjartansson, O | 1 |
| Nyberg-Hansen, R | 1 |
| Rootwelt, K | 1 |
| Wiberg, J | 1 |
| Di Piero, V | 1 |
| Pozzilli, C | 1 |
| Pantano, P | 1 |
| Grasso, MG | 1 |
| Fieschi, C | 1 |
| Chollet, F | 1 |
| Celsis, P | 1 |
| Clanet, M | 1 |
| Guiraud-Chaumeil, B | 1 |
| Rascol, A | 1 |
| Marc-Vergnes, JP | 1 |
| Boysen, G | 1 |
| Brun, B | 1 |
| Engell, HC | 1 |
| Kassiotis, P | 1 |
| Steinling, M | 1 |
| Derlon, JM | 1 |
| Michailov, ML | 1 |
| Kunov, A | 1 |
| Gomensoro, JB | 1 |
| Regli, F | 1 |
| Yamaguchi, T | 1 |
| Waltz, AG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| C-arm Cone Beam CTA and CTP With Acetazolamide Challenge in Aneurysmal Subarachnoid Hemorrhage: Evaluating Predictability for Early Ischemia in Cerebral Vasospasm[NCT03377049] | Phase 4 | 11 participants (Actual) | Interventional | 2019-07-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Clinical neurological deterioration not attributable to other causes, mores specifically not due to re-bleeding, hydrocephalus, or metabolic changes. (NCT03377049)
Timeframe: Day 1-14 during the hospitalization
| Intervention | Participants (Count of Participants) |
|---|---|
| Acetazolamide Challenge | 2 |
Using perfusion map values, relative percent change will be calculated (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
| Intervention | percent change (Mean) |
|---|---|
| Acetazolamide Challenge | 19.785 |
Using perfusion map values, relative percent change will be calculated (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
| Intervention | percent change (Mean) |
|---|---|
| Acetazolamide Challenge | 21.659 |
The data that will be statistically compared is the pre-diamox perfusion in comparison to the post-diamox perfusion. A statistically significant change increase in CBF represents an appropriate response to Diamox. Lack of change in CBF or decrease in CBF could be suggestive of potential for developing vasospasm. (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
| Intervention | percent change (Mean) |
|---|---|
| Acetazolamide Challenge | 20.722 |
2 reviews available for acetazolamide and Ischemic Attack, Transient
| Article | Year |
|---|---|
Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Cerebral Angiography; Cerebral Infa | 2011 |
CURRENT THERAPEUTIC CONCEPTS OF CEREBRAL AND MYOCARDIAL VASCULAR DISEASE.
Topics: Acetazolamide; Anticoagulants; Brain Ischemia; Cerebrovascular Disorders; Coronary Disease; Histamin | 1964 |
1 trial available for acetazolamide and Ischemic Attack, Transient
| Article | Year |
|---|---|
Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease.
Topics: Acetazolamide; Aged; Blood Flow Velocity; Cholesterol, LDL; Cognition Disorders; Dementia, Vascular; | 2001 |
48 other studies available for acetazolamide and Ischemic Attack, Transient
| Article | Year |
|---|---|
Contralateral improvement of cerebrovascular reactivity and TIA frequency after unilateral revascularization surgery in moyamoya vasculopathy.
Topics: Acetazolamide; Cerebrovascular Circulation; Humans; Ischemic Attack, Transient; Moyamoya Disease; To | 2021 |
[Bilateral carotid artery occlusion: prognosis and neurosonological features].
Topics: Acetazolamide; Aged; Aged, 80 and over; Angiography; Brain Ischemia; Carotid Stenosis; Collateral Ci | 2014 |
Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
Topics: Acetazolamide; Adolescent; Aphasia; Brain; Brain Edema; Cerebral Angiography; Cerebral Infarction; C | 2010 |
Extracranial-intracranial (EC-IC) bypass of symptomatic middle cerebral artery (MCA) total occlusion for haemodynamic impairment patients.
Topics: Acetazolamide; Adult; Aged; Female; Hemodynamics; Humans; Infarction, Middle Cerebral Artery; Intrac | 2012 |
Hyperventilation-induced limb shaking TIA in Moyamoya disease.
Topics: Acetazolamide; Adult; Angiography; Carbonic Anhydrase Inhibitors; Carotid Stenosis; Collateral Circu | 2003 |
Differences in acetazolamide vasoreactivity in patients with acute and chronic occlusion of the internal carotid artery.
Topics: Acetazolamide; Carotid Artery, Internal; Carotid Stenosis; Cerebrovascular Circulation; Functional L | 2003 |
VASODILATORS IN CEREBRAL VASCULAR INSUFFICIENCY.
Topics: Acetazolamide; Blood Flow Velocity; Brain Ischemia; Carbon Dioxide; Cerebrovascular Circulation; Cer | 1963 |
Cerebral vasoreactivity does not predict cerebral ischaemia during carotid endarterectomy.
Topics: Acetazolamide; Aged; Aged, 80 and over; Blood Flow Velocity; Brain Ischemia; Carotid Stenosis; Cereb | 2003 |
Hemodynamic changes in limb shaking TIA associated with anterior cerebral artery stenosis.
Topics: Acetazolamide; Anterior Cerebral Artery; Anticoagulants; Carbonic Anhydrase Inhibitors; Cerebral Ang | 2004 |
[Recurrent hemispheric symptoms without proof of ischemia].
Topics: Acetazolamide; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Diagnosis, Differential; | 2004 |
Differentiating hemodynamic compromise by the OEF response to acetazolamide in occlusive vascular disease.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Female; Hemodynamics; Humans; Ischemic Atta | 2005 |
Prevention of cerebral ischemia during carotid occlusion by acetazolamide.
Topics: Acetazolamide; Blood Gas Analysis; Blood Pressure; Carotid Artery Thrombosis; Endarterectomy; Humans | 1967 |
A study of acetazolamide-induced changes in cerebral blood flow using 99mTc HMPAO SPECT in patients with cerebrovascular disease.
Topics: Acetazolamide; Adult; Aged; Brain; Brain Mapping; Carotid Artery, Internal; Carotid Stenosis; Cerebr | 1995 |
Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography.
Topics: Acetazolamide; Adolescent; Adult; Aged; Blood Flow Velocity; Brain; Brain Ischemia; Cerebral Cortex; | 1995 |
Correlation of xenon-enhanced computed tomography-defined cerebral blood flow reactivity and collateral flow patterns.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Brain; Carotid Artery Diseases; Cerebral Angiography; | 1994 |
Surgically induced angiogenesis to compensate for hemodynamic cerebral ischemia.
Topics: Acetazolamide; Adolescent; Adult; Brain; Cerebral Arteries; Cerebrovascular Circulation; Child; Coll | 1994 |
Prediction of cerebral infarction due to vasospasm following aneurysmal subarachnoid haemorrhage using acetazolamide-activated 123I-IMP SPECT.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Amphetamines; Aneurysm, Ruptured; Brain; Cerebral Inf | 1993 |
Abnormal cerebral vasodilation in aneurysmal subarachnoid hemorrhage: use of serial 133Xe cerebral blood flow measurement plus acetazolamide to assess cerebral vasospasm.
Topics: Acetazolamide; Adult; Cerebral Angiography; Cerebrovascular Circulation; Female; Humans; Intracrania | 1993 |
Persisting perfusion defect in transient ischemic attacks: a new clinically useful subgroup?
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Brain; Carotid Arteries; Cerebral Infarction; Cerebro | 1996 |
Extracranial intravascular vasodilatory response to acetazolamide and magnetic resonance angiography.
Topics: Acetazolamide; Aged; Aged, 80 and over; Blood Flow Velocity; Blood Volume; Carotid Arteries; Carotid | 1996 |
Early cerebral blood flow and vascular reactivity to acetazolamide in predicting the outcome after ruptured cerebral aneurysm.
Topics: Acetazolamide; Aneurysm, Ruptured; Blood Flow Velocity; Brain; Brain Ischemia; Glasgow Coma Scale; H | 1996 |
Xe-CT in cerebrovascular disease and moyamoya disease.
Topics: Acetazolamide; Brain; Brain Ischemia; Carbon Dioxide; Hemodynamics; Humans; Ischemic Attack, Transie | 1996 |
EC-IC bypass in patients with chronic hemodynamic insufficiency.
Topics: Acetazolamide; Adult; Aged; Brain; Brain Ischemia; Carotid Stenosis; Cerebral Revascularization; Fem | 1996 |
Time course of the acetazolamide effect in patients with extracranial carotid artery disease.
Topics: Acetazolamide; Blood Flow Velocity; Carbonic Anhydrase Inhibitors; Carotid Stenosis; Cerebral Arteri | 1996 |
Cerebrovascular reserve capacity in patients with occlusive cerebrovascular disease: assessment with dynamic susceptibility contrast-enhanced MR imaging and the acetazolamide stimulation test.
Topics: Acetazolamide; Adult; Aged; Blood Volume; Cerebrovascular Circulation; Contrast Media; Drug Combinat | 1996 |
Changes in cortical CBF and vascular response after vascular reconstruction in patients with adult onset moyamoya disease.
Topics: Acetazolamide; Adult; Cerebral Angiography; Cerebral Cortex; Cerebral Revascularization; Female; Hum | 1996 |
Predictability of extracranial/intracranial bypass function: a retrospective study of patients with occlusive cerebrovascular disease.
Topics: Acetazolamide; Adult; Aged; Brain; Carotid Artery, Internal; Carotid Stenosis; Cerebral Revasculariz | 1997 |
High signal intensity on T2-weighted magnetic resonance imaging and cerebral hemodynamic reserve in carotid occlusive disease.
Topics: Acetazolamide; Aged; Brain Ischemia; Carotid Stenosis; Cerebrovascular Circulation; Female; Humans; | 1997 |
Vasodilatory responses and magnetic resonance angiography. Extracranial and intracranial intravascular flow data.
Topics: Acetazolamide; Aged; Basilar Artery; Carotid Artery, Internal; Carotid Stenosis; Case-Control Studie | 1997 |
Cerebrovascular reserve capacity many years after vasospasm due to aneurysmal subarachnoid hemorrhage. A transcranial Doppler study with acetazolamide test.
Topics: Acetazolamide; Adolescent; Adult; Blood Flow Velocity; Cerebrovascular Circulation; Female; Follow-U | 1997 |
Acetazolamide reactivity in atherothrombotic, cardioembolic and lacunar infarctions.
Topics: Acetazolamide; Aged; Case-Control Studies; Cerebral Infarction; Cerebrovascular Circulation; Female; | 2000 |
Cerebral perfusion and haemodynamics measured by SPET in symptom-free patients with transient ischaemic attack: clinical implications.
Topics: Acetazolamide; Aged; Cerebrovascular Circulation; Diuretics; Female; Humans; Ischemic Attack, Transi | 2001 |
[Cerebral blood flow in the determination of vasospasm and surgical decision].
Topics: Acetazolamide; Aneurysm, Ruptured; Cerebrovascular Circulation; Humans; Intracranial Aneurysm; Ische | 1992 |
[Cerebral blood flow distribution and reactivity during the symptom-free stages of transient ischemic attacks--a 99mTc-HMPAO SPECT study].
Topics: Acetazolamide; Adult; Aged; Cerebrovascular Circulation; Female; Humans; Ischemic Attack, Transient; | 1992 |
Acetazolamide enhanced single photon emission computed tomography (SPECT) evaluation of cerebral perfusion before and after carotid endarterectomy.
Topics: Acetazolamide; Aged; Aged, 80 and over; Blindness; Carotid Stenosis; Cerebrovascular Circulation; Ce | 1992 |
Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carotid Artery Diseases; | 1992 |
Nuclear hemodynamic vertebrobasilar insufficiency. A new approach with the xenon Xe 133 method.
Topics: Acetazolamide; Adult; Aged; Blood Volume; Brain Stem; Cerebellum; Cerebrovascular Circulation; Domin | 1991 |
[The value of the acetazolamide stimulation test with 99mTc-HMPAO-SPECT in reversible cerebrovascular insufficiency].
Topics: Acetazolamide; Aged; Aged, 80 and over; Female; Humans; Ischemic Attack, Transient; Male; Middle Age | 1991 |
Cerebral vasoreactivity and blood flow before and 3 months after carotid endarterectomy.
Topics: Acetazolamide; Carotid Arteries; Carotid Artery Diseases; Cerebrovascular Circulation; Endarterectom | 1990 |
Acetazolamide effects on cerebral blood flow in acute reversible ischemia.
Topics: Acetazolamide; Aged; Aged, 80 and over; Cerebrovascular Circulation; Female; Humans; Ischemic Attack | 1989 |
SPECT study of cerebral blood flow reactivity after acetazolamide in patients with transient ischemic attacks.
Topics: Acetazolamide; Adult; Aged; Carotid Artery Diseases; Carotid Artery, Internal; Cerebral Cortex; Cere | 1989 |
Evaluation of the regional cerebral vasodilatory capacity before carotid endarterectomy by the acetazolamide test.
Topics: Acetazolamide; Adult; Aged; Brain; Carotid Artery Diseases; Cerebrovascular Disorders; Endarterectom | 1987 |
[Regional cerebral blood flow and its reactivity to acetazolamide in transient ischemic attacks. Study of 20 cases by gamma emission tomography].
Topics: Acetazolamide; Adult; Aged; Cerebrovascular Circulation; Color; Female; Hemodynamics; Humans; Ischem | 1987 |
Tomographic cerebral blood flow measurements in patients with ischemic cerebrovascular disease and evaluation of the vasodilatory capacity by the acetazolamide test.
Topics: Acetazolamide; Aminophylline; Blood Flow Velocity; Brain Ischemia; Carotid Artery Diseases; Cerebral | 1988 |
[Cerebral blood volume and cerebral blood flow. Practical significance of combined measurements in the evaluation of the ischemic risk].
Topics: Acetazolamide; Blood Volume; Brain; Brain Ischemia; Carotid Artery Diseases; Cerebrovascular Circula | 1986 |
[10 years' diuretic therapy and its complications].
Topics: Acetazolamide; Acidosis; Alkalosis; Anuria; Benzothiadiazines; Carbonic Anhydrase Inhibitors; Coma; | 1974 |
[Use of hydergine in acute ischemic pathology of the brain].
Topics: Acetazolamide; Adult; Aged; Aminophylline; Arrhythmias, Cardiac; Carbon Dioxide; Cerebrovascular Cir | 1967 |
Effects of hyperventilation, hypocapnia, and acetazolamide on experimental cerebral ischemia and infarction.
Topics: Acetazolamide; Animals; Brain Edema; Carbon Dioxide; Cats; Cerebrovascular Circulation; Cerebrovascu | 1972 |